In CLL cells from untreated patients, NGAL induced cell survival in 19 of the 25 CLL samples tested (Figure 5C), and this protective effect appeared independent of the Binet stage (stage A (n = 15) vs. stage B/C (n = 4), p = 0.883). The gene discussed is LCN2; the disease is B-cell chronic lymphocytic leukemia.